Share

    


Home / Search Results

Search Results

Search Publications

Search Again?

Filter By Content Type

Filter By Topic

ACCC_SkinCancerSpotlight_Nebraska.indd ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● …
As interest continues to build around multi-cancer early detection, hear what care teams need to know about the technology and the legislative outlook for coverage for this revolutionary testing.
ACCC_SkinCancerSpotlight_Schar.indd ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● …
ACCC_SkinCancerSpotlight_Schar.indd ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● …
ACCC_SkinCancerSpotlight_MDA.indd ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● …
ACCC_SkinCancerSpotlight_Schar.indd ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● …
The Association of Community Cancer Centers (ACCC) is announcing the release of a new tool intended to facilitate education and adoption of new clinical and technological advancements in diagnosis, staging, and treatment of cancer. Referred to as the OPTIC Resource Library, this tool offers resources for the multidisciplinary care team to use to support adoption of innovations, emerging practices, …
Learn how multidisciplinary care coordination and timely diagnosis are critical in the health outcomes of patients with SCLC.
Click to enter a date Choose an item Enter First & Last Name [INSERT YOUR COMPANY’S NAME HERE] Dear Choose an item Enter your last name The Iowa Oncology Society (IOS) Board of Directors invites [INSERT YOUR COMPANY’S NAME HERE] to attend and display at our IOS 2023 Spring Conference on March 10, 2023 at the Des Moines Marriott Downtown in Des Moines, Iowa. The $2,500 registration …
Click to enter a date Choose an item Enter First & Last Name [INSERT YOUR COMPANY’S NAME HERE] Dear Choose an item Enter your last name The West Virginia Oncology Society (WVOS) Board of Directors invites [INSERT YOUR COMPANY’S NAME HERE] to attend and display at our WVOS 2023 Spring Conference on March 24, 2023 at the Stonewall Resort in Roanoke, West Virginia. The $2,500 registration …
ACCC shares how a precision medicine steward—a dedicated navigator focused specifically on biopsy samples and biomarker testing processes and results—can make a daunting biomarker testing process incredibly efficient for cancer programs and practices everywhere.
Accelerated Approvals Reconsidered Blenrep (belantamab mafodotin-blmf) - GSK said Tuesday that following a request from FDA, it will withdraw its blood cancer drug from the U.S. market. The decision comes a little more than two years after the BCMA-directed antibody and microtubule inhibitor conjugate was granted an accelerated approval as 5th-line therapy for adult patients with relapsed …
ASSOCIATION OF COMMUNITY CANCER CENTERS PROVIDING EQUITABLE CARE TO PATIENTS WITH BLADDER CANCER Patients face many challenges and roadblocks on their treatment path, which can be exacerbated by social determinants of health and health disparities. Cancer care team members can take evidence-based steps to improve quality care and minimize disparities for patients with bladder cancer. Common …
ASSOCIATION OF COMMUNITY CANCER CENTERS Effective Practices in Bladder Cancer Care: MITIGATING DISPARITIES WITH GUIDELINE-BASED CARE Despite the expansion of therapeutic options for patients with bladder cancer (see Box 1), disparities per-sist in the United States (U.S.). Receipt of guideline- concordant treatment is suboptimal across the bladder cancer spectrum, especially for Black …
FIGURE 1. Cumulative Allowed Costs by Stage and Years Following Bladder Cancer Diagnosis ASSOCIATION OF COMMUNITY CANCER CENTERS Effective Practices in Bladder Cancer Care: ADDRESSING FINANCIAL BARRIERS TO QUALITY CARE Bladder cancer is well known to be one of the costliest cancers to treat. With advancements in treatment options (newer drugs and therapies), more costs are being shifted …
ASSOCIATION OF COMMUNITY CANCER CENTERS Effective Practices in Bladder Cancer Care: ENGAGING PATIENTS IN THEIR CARE Goals-of-Care Conversations As with all cancers, a bladder cancer diagnosis can be scary and overwhelming for both patients and their caregivers. Compared to other cancer types, however, patient experience of bladder cancer care is especially poor.1 For people with …
ASSOCIATION OF COMMUNITY CANCER CENTERS PROVIDING EQUITABLE CARE TO PATIENTS WITH BLADDER CANCER Patients face many challenges and roadblocks on their treatment path, which can be exacerbated by social determinants of health and health disparities. Cancer care team members can take evidence-based steps to improve quality care and minimize disparities for patients with bladder cancer. Common …
FIGURE 1. Cumulative Allowed Costs by Stage and Years Following Bladder Cancer Diagnosis ASSOCIATION OF COMMUNITY CANCER CENTERS Effective Practices in Bladder Cancer Care: ADDRESSING FINANCIAL BARRIERS TO QUALITY CARE Bladder cancer is well known to be one of the costliest cancers to treat. With advancements in treatment options (newer drugs and therapies), more costs are being shifted …